179 related articles for article (PubMed ID: 17848618)
1. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.
Colla S; Tagliaferri S; Morandi F; Lunghi P; Donofrio G; Martorana D; Mancini C; Lazzaretti M; Mazzera L; Ravanetti L; Bonomini S; Ferrari L; Miranda C; Ladetto M; Neri TM; Neri A; Greco A; Mangoni M; Bonati A; Rizzoli V; Giuliani N
Blood; 2007 Dec; 110(13):4464-75. PubMed ID: 17848618
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of growth 4 (ING4) inhibits hypoxia-induced EMT by decreasing HIF-1α and snail in HK2 cells.
Lu L; Li J; Le Y; Jiang H
Acta Histochem; 2019 Aug; 121(6):695-703. PubMed ID: 31239073
[TBL] [Abstract][Full Text] [Related]
4. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).
Ozer A; Wu LC; Bruick RK
Proc Natl Acad Sci U S A; 2005 May; 102(21):7481-6. PubMed ID: 15897452
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1.
Li J; Li G
Cancer Res; 2010 Dec; 70(24):10445-53. PubMed ID: 21056991
[TBL] [Abstract][Full Text] [Related]
6. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
Xie Y; Lv H; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2011 Dec; 26(6):681-95. PubMed ID: 21988227
[TBL] [Abstract][Full Text] [Related]
7. Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4.
Ozer A; Bruick RK
Cell Cycle; 2005 Sep; 4(9):1153-6. PubMed ID: 16096374
[TBL] [Abstract][Full Text] [Related]
8. Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients.
Colla S; Morandi F; Lazzaretti M; Rizzato R; Lunghi P; Bonomini S; Mancini C; Pedrazzoni M; Crugnola M; Rizzoli V; Giuliani N
Leukemia; 2005 Dec; 19(12):2166-76. PubMed ID: 16208410
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.
Storti P; Bolzoni M; Donofrio G; Airoldi I; Guasco D; Toscani D; Martella E; Lazzaretti M; Mancini C; Agnelli L; Patrene K; Maïga S; Franceschi V; Colla S; Anderson J; Neri A; Amiot M; Aversa F; Roodman GD; Giuliani N
Leukemia; 2013 Aug; 27(8):1697-706. PubMed ID: 23344526
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
Ria R; Catacchio I; Berardi S; De Luisi A; Caivano A; Piccoli C; Ruggieri V; Frassanito MA; Ribatti D; Nico B; Annese T; Ruggieri S; Guarini A; Minoia C; Ditonno P; Angelucci E; Derudas D; Moschetta M; Dammacco F; Vacca A
Clin Cancer Res; 2014 Feb; 20(4):847-58. PubMed ID: 24297864
[TBL] [Abstract][Full Text] [Related]
12. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
13. ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients.
Lu J; Tang Y; Cheng Y; Zhang G; Yip A; Martinka M; Dong Z; Zhou J; Li G
Br J Cancer; 2013 Nov; 109(11):2842-52. PubMed ID: 24157826
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.
Zhao Y; Li Z; Sheng W; Miao J; Yang J
Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Aug; 14(4):369-78. PubMed ID: 25326586
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis.
Xie YF; Sheng W; Xiang J; Zhang H; Ye Z; Yang J
Cancer Biother Radiopharm; 2009 Apr; 24(2):261-9. PubMed ID: 19409049
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.
Cai L; Li X; Zheng S; Wang Y; Wang Y; Li H; Yang J; Sun J
Melanoma Res; 2009 Feb; 19(1):1-7. PubMed ID: 19430401
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
Li Y; Zhao L; Qi Y; Yang X
Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
[TBL] [Abstract][Full Text] [Related]
19. The implication of serum HLA-G in angiogenesis of multiple myeloma.
Wang C; Su NW; Hsu K; Kao CW; Chang MC; Chang YF; Lim KH; Chiang YH; Chang YC; Sung MT; Wu HH; Chen CG
Mol Med; 2024 Jun; 30(1):86. PubMed ID: 38877399
[TBL] [Abstract][Full Text] [Related]
20. [Expression levels of MMP-14, ING4 and HIF-1α in 60 patients with oral squamous cell carcinoma and their clinical significance].
Fu ZY; Tao F
Shanghai Kou Qiang Yi Xue; 2020 Dec; 29(6):642-646. PubMed ID: 33778834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
